Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between physical capacity and depression in heart failure patients undergoing hybrid comprehensive telerehabilitation vs. usual care: subanalysis from the TELEREH-HF Randomized Clinical Trial.
Piotrowicz E, Mierzyńska A, Jaworska I, Opolski G, Banach M, Zaręba W, Kowalik I, Pencina M, Orzechowski P, Szalewska D, Pluta S, Glowczynska R, Kalarus Z, Irzmanski R, Piotrowicz R. Piotrowicz E, et al. Among authors: pencina m. Eur J Cardiovasc Nurs. 2022 Aug 29;21(6):568-577. doi: 10.1093/eurjcn/zvab125. Eur J Cardiovasc Nurs. 2022. PMID: 35037037 Clinical Trial.
Hybrid comprehensive telerehabilitation in heart failure patients (TELEREH-HF): A randomized, multicenter, prospective, open-label, parallel group controlled trial-Study design and description of the intervention.
Piotrowicz E, Piotrowicz R, Opolski G, Pencina M, Banach M, Zaręba W. Piotrowicz E, et al. Among authors: pencina m. Am Heart J. 2019 Nov;217:148-158. doi: 10.1016/j.ahj.2019.08.015. Epub 2019 Aug 22. Am Heart J. 2019. PMID: 31654944 Clinical Trial.
Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes.
Pandey A, Golwala H, Xu H, DeVore AD, Matsouaka R, Pencina M, Kumbhani DJ, Hernandez AF, Bhatt DL, Heidenreich PA, Yancy CW, de Lemos JA, Fonarow GC. Pandey A, et al. Among authors: pencina m. JACC Heart Fail. 2016 Dec;4(12):935-946. doi: 10.1016/j.jchf.2016.07.003. JACC Heart Fail. 2016. PMID: 27908393 Free article.
Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey.
Zdrojewski T, Solnica B, Cybulska B, Bandosz P, Rutkowski M, Stokwiszewski J, Gaciong Z, Banach M, Wojtyniak B, Pencina M, Wyrzykowski B. Zdrojewski T, et al. Among authors: pencina m. Kardiol Pol. 2016;74(3):213-23. doi: 10.5603/KP.2016.0029. Kardiol Pol. 2016. PMID: 27004543 Free article.
Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial.
Banovic M, Iung B, Bartunek J, Asanin M, Beleslin B, Biocina B, Casselman F, da Costa M, Deja M, Gasparovic H, Kala P, Labrousse L, Loncar Z, Marinkovic J, Nedeljkovic I, Nedeljkovic M, Nemec P, Nikolic SD, Pencina M, Penicka M, Ristic A, Sharif F, Van Camp G, Vanderheyden M, Wojakowski W, Putnik S. Banovic M, et al. Among authors: pencina m. Am Heart J. 2016 Apr;174:147-53. doi: 10.1016/j.ahj.2016.02.001. Epub 2016 Feb 9. Am Heart J. 2016. PMID: 26995381 Clinical Trial.
Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.
Sinning JM, Wollert KC, Sedaghat A, Widera C, Radermacher MC, Descoups C, Hammerstingl C, Weber M, Stundl A, Ghanem A, Widder J, Vasa-Nicotera M, Mellert F, Schiller W, Bauersachs J, Zur B, Holdenrieder S, Welz A, Grube E, Pencina MJ, Nickenig G, Werner N, Kempf T. Sinning JM, et al. Among authors: pencina mj. Am Heart J. 2015 Oct;170(4):821-9. doi: 10.1016/j.ahj.2015.07.003. Epub 2015 Jul 10. Am Heart J. 2015. PMID: 26386807 Free article.
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
Mauri L, Kereiakes DJ, Normand SL, Wiviott SD, Cohen DJ, Holmes DR, Bangalore S, Cutlip DE, Pencina M, Massaro JM. Mauri L, et al. Among authors: pencina m. Am Heart J. 2010 Dec;160(6):1035-41, 1041.e1. doi: 10.1016/j.ahj.2010.07.038. Am Heart J. 2010. PMID: 21146655 Clinical Trial.
Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site.
Mauri L, Normand SL, Pencina M, Cutlip DE, Jeon C, Dreyer P, Kuntz RE, Baim DS, Jacobs AK. Mauri L, et al. Among authors: pencina m. Am Heart J. 2011 Nov;162(5):826-31. doi: 10.1016/j.ahj.2011.08.018. Am Heart J. 2011. PMID: 22093197 Clinical Trial.
431 results